Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

U. of Colorado team developing ’Flu Chip’ for fast, accurate diagnosis

11.11.2003


From left to right, CU-Boulder Associate Professor Robert Kuptcha, undergraduate student Amy Reppert, graduate student Michael Townsend and team leader and Professor Kathy Rowlen of the chemistry and biochemistry department. Photo courtesy of Casey Cass, University of Colorado. The Flu Chip image was accessed from the website of Leming Shi of Jefferson, Ark.


A team of researchers at the University of Colorado at Boulder is developing a "Flu Chip" that will aid physicians in swiftly diagnosing respiratory illness for future flu seasons.

The Flu Chip will allow doctors and public health officials to differentiate between three types of influenza and other viruses that cause similar clinical symptoms, such as severe acute respiratory syndrome, or SARS.

The CU team, led by Professor Kathy Rowlen and co-principal investigator and Associate Professor Robert Kuchta of the chemistry and biochemistry department, recently received a $1.7 million grant from the National Institute of Infectious Disease to develop the chip in collaboration with the Centers for Disease Control and Prevention in Atlanta, the World Health Organization and Bio-Rad Laboratories in Hercules, Calif.



According to Rowlen, influenza A viral infections have had a dramatic impact on humans, with an estimated 500,000 deaths worldwide each year and significant economic impact resulting from direct and indirect loss of productivity during infection.

"For comparison, the corona virus that caused the recent outbreak of SARS has claimed less than 1,000 lives to date," said Rowlen. "However, as demonstrated by the public response to SARS, of great concern is the ability of viruses to undergo natural or engineered genetic change that could result in a virus capable of rapid and lethal spread within the population."

One of the most dramatic events in influenza history was the so-called "Spanish Flu" pandemic of 1918-1919. In less than a year, between 20 million and 40 million people died from influenza, with an estimated one fifth of the world’s population infected.

"Because it is readily transmitted, primarily as an airborne pathogen and because the virus can be genetically engineered into novel forms, influenza A also represents a serious biodefense concern," Rowlen said.

"Rapid identification of any biological pathogen, such as flu A, anthrax or SARS, requires a reliable and relatively inexpensive analytical system that can be widely manufactured and distributed," she said. "Current commercial technology for rapid identification of influenza A does not provide any genetic information and therefore cannot provide investigators at the CDC or the World Health Organization with adequate information for managing local epidemics or worldwide pandemics."

DNA microarrays, which are the basis for the Flu Chip, represent a promising technology for accurate and relatively rapid pathogen identification based on genetic "signatures."

The general structure of a DNA microarray is a well-defined arrangement of micron-sized spots on an optically flat surface, each of which contains a layer of relatively short strands of DNA designed to capture a specific genetic sequence from a sample.

Each spot -- about one-thousandth of an inch across -- is deposited by a robot. Patient samples can be evaluated through a fairly simple procedure called hybridization. Hybridization is achieved by heating and slowly cooling the sample processed from a patient with the microarray.

The microarray is then developed to produce an image, she said. By knowing the identity of specific DNA segments known as oligonucleotides at any location within the array, one can determine which bits of genetic information were present in the patient sample by reading the image.

The CU team of researchers is developing the Flu Chip as an inexpensive way to swiftly -- within an hour or less -- screen for influenza A, the most bothersome strain of flu, as well as influenza B and C, SARS and respiratory syncytial virus, which is a primary cause of respiratory illness in infants. "In addition, the Flu Chip could play a significant role in detecting and containing viral outbreaks or alerting officials to an ’engineered’ influenza virus," Rowlen said.

Other members of the CU-Boulder Flu Chip team include post-doctoral research associate Chad Moore, graduate students Michael Townsend and James Smagala, and undergraduate student Amy Reppert.

"In order to address the needs in developing nations, one of our primary objectives is to create an inexpensive and field-portable test kit for respiratory illness," said Rowlen. "The goal is to provide an important new tool to the World Health Organization for global screening of respiratory illness," she said.

Kathy Rowlen | CU-Boulder
Further information:
http://www.colorado.edu/news/
http://www.colorado.edu/news/releases/2003/434.html

More articles from Life Sciences:

nachricht NUI Galway highlights reproductive flexibility in hydractinia, a Galway bay jellyfish
24.02.2020 | National University of Ireland Galway

nachricht Shaping the rings of molecules
24.02.2020 | University of Montreal

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A step towards controlling spin-dependent petahertz electronics by material defects

The operational speed of semiconductors in various electronic and optoelectronic devices is limited to several gigahertz (a billion oscillations per second). This constrains the upper limit of the operational speed of computing. Now researchers from the Max Planck Institute for the Structure and Dynamics of Matter in Hamburg, Germany, and the Indian Institute of Technology in Bombay have explained how these processes can be sped up through the use of light waves and defected solid materials.

Light waves perform several hundred trillion oscillations per second. Hence, it is natural to envision employing light oscillations to drive the electronic...

Im Focus: Freiburg researcher investigate the origins of surface texture

Most natural and artificial surfaces are rough: metals and even glasses that appear smooth to the naked eye can look like jagged mountain ranges under the microscope. There is currently no uniform theory about the origin of this roughness despite it being observed on all scales, from the atomic to the tectonic. Scientists suspect that the rough surface is formed by irreversible plastic deformation that occurs in many processes of mechanical machining of components such as milling.

Prof. Dr. Lars Pastewka from the Simulation group at the Department of Microsystems Engineering at the University of Freiburg and his team have simulated such...

Im Focus: Skyrmions like it hot: Spin structures are controllable even at high temperatures

Investigation of the temperature dependence of the skyrmion Hall effect reveals further insights into possible new data storage devices

The joint research project of Johannes Gutenberg University Mainz (JGU) and the Massachusetts Institute of Technology (MIT) that had previously demonstrated...

Im Focus: Making the internet more energy efficient through systemic optimization

Researchers at Chalmers University of Technology, Sweden, recently completed a 5-year research project looking at how to make fibre optic communications systems more energy efficient. Among their proposals are smart, error-correcting data chip circuits, which they refined to be 10 times less energy consumptive. The project has yielded several scientific articles, in publications including Nature Communications.

Streaming films and music, scrolling through social media, and using cloud-based storage services are everyday activities now.

Im Focus: New synthesis methods enhance 3D chemical space for drug discovery

After helping develop a new approach for organic synthesis -- carbon-hydrogen functionalization -- scientists at Emory University are now showing how this approach may apply to drug discovery. Nature Catalysis published their most recent work -- a streamlined process for making a three-dimensional scaffold of keen interest to the pharmaceutical industry.

"Our tools open up whole new chemical space for potential drug targets," says Huw Davies, Emory professor of organic chemistry and senior author of the paper.

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

70th Lindau Nobel Laureate Meeting: Around 70 Laureates set to meet with young scientists from approx. 100 countries

12.02.2020 | Event News

11th Advanced Battery Power Conference, March 24-25, 2020 in Münster/Germany

16.01.2020 | Event News

Laser Colloquium Hydrogen LKH2: fast and reliable fuel cell manufacturing

15.01.2020 | Event News

 
Latest News

NUI Galway highlights reproductive flexibility in hydractinia, a Galway bay jellyfish

24.02.2020 | Life Sciences

KIST researchers develop high-capacity EV battery materials that double driving range

24.02.2020 | Materials Sciences

How earthquakes deform gravity

24.02.2020 | Earth Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>